Nexalin Technology (NXL) Income towards Parent Company (2021 - 2026)
Nexalin Technology (NXL) posted Income towards Parent Company of -$2.2 million for Q2 2026, down 6.79% on a QoQ basis from -$2.1 million in Q1 2026, and down 41.63% year-over-year from -$3.8 million in Q2 2025.
Analysis
Nexalin Technology (NXL) Income towards Parent Company (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Income towards Parent Company for 6 years, with the latest figure at -$2.2 million in Q2 2026.
- On a quarterly basis, Income towards Parent Company fell 41.63% year-over-year to -$2.2 million in Q2 2026; TTM through Jun 2026 was -$9.0 million, a 1.57% decrease from a year earlier, with the FY2025 full-year figure at -$6.5 million, up 14.67% from the prior year.
- Income towards Parent Company was -$2.2 million for Q2 2026 at Nexalin Technology, down from -$2.1 million in the prior quarter.
- The five-year high for Income towards Parent Company was -$303646.0 in Q3 2022, with the low at -$2.8 million in Q4 2024.
- Average Income towards Parent Company over 5 years is -$1.5 million, with a median of -$1.4 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Income towards Parent Company surged 83.34% in 2022, then sank 656.54% in 2023.
- Over 5 years, Income towards Parent Company stood at -$736919.0 in 2022, then fell by 5.94% to -$780669.0 in 2023, then plunged by 262.95% to -$2.8 million in 2024, then climbed by 16.12% to -$2.4 million in 2025, then advanced by 5.79% to -$2.2 million in 2026.
- The last three Income towards Parent Company figures came in at -$2.2 million (Q2 2026), -$2.1 million (Q1 2026), and -$2.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.24 Mn |
| Mar 31, 2026 | -2.10 Mn |
| Dec 31, 2025 | -2.38 Mn |
| Sep 30, 2025 | -2.28 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.99 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | -2.45 Mn |
| Jun 30, 2024 | -1.28 Mn |
| Mar 31, 2024 | -1.05 Mn |
| Dec 31, 2023 | -780,669.00 |
| Sep 30, 2023 | -2.30 Mn |
| Jun 30, 2023 | -822,437.00 |
| Mar 31, 2023 | -748,414.00 |
| Dec 31, 2022 | -736,919.00 |
| Sep 30, 2022 | -303,646.00 |
| Jun 30, 2022 | -445,103.00 |
| Mar 31, 2022 | -393,249.00 |
| Dec 31, 2021 | -595,928.00 |
| Sep 30, 2021 | -1.82 Mn |